Showing results (461-470 of 490) with videos related to
Sort By:
Pageof 49
Infection and Immunity|August 19, 2000
Chronic Helicobacter pylori infection induces an apoptosis-resistant phenotype associated with decreased expression of p27(kip1)H Shirin, E M Sordillo, T K Kolevska, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 22, 2018
Houston Consensus Conference on Testing for Helicobacter pylori Infection in the United StatesHashem B El-Serag, John Y Kao, Fasiha Kanwal, et al.Frontiers in Neuroscience|May 31, 2021
Autonomous Flying With Neuromorphic SensingPatricia P Parlevliet, Andrey Kanaev, Chou P Hung, et al.The Journal of Clinical Investigation|March 10, 2001
Helicobacter pylori strain-specific differences in genetic content, identified by microarray, influence host inflammatory responsesD A Israel, N Salama, C N Arnold, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2008
Decreased expression of gastrokine 1 and the trefoil factor interacting protein TFIZ1/GKN2 in gastric cancer: influence of tumor histology and relationship to prognosisSteven F Moss, Jin-Woo Lee, Edmond Sabo, et al.Oncogene|April 8, 2011
Resistance or sensitivity of Wilms' tumor to anti-FZD7 antibody highlights the Wnt pathway as a possible therapeutic targetN Pode-Shakked, O Harari-Steinberg, Y Haberman-Ziv, et al.Prehospital and Disaster Medicine|September 14, 2019
The Triage of Older Adults with Physiologic Markers of Serious Injury Using a State-Wide Prehospital PlanMatthew H Meyers, Trent L Wei, Julianne M Cyr, et al.British Journal of Pharmacology|August 6, 2000
Characterization of SB-271046: a potent, selective and orally active 5-HT(6) receptor antagonistC Routledge, S M Bromidge, S F Moss, et al.The Journal of Antibiotics|December 1, 1996
Novel C-2 substituted carbapenem derivatives. Part II. Synthesis and structure-activity relationships of isoxazolin-2-yl, isoxazolidin-2-yl and 2-pyrazolin-2-yl carbapenems generated using 1,3-dipolar cycloaddition chemistryG Burton, G J Clarke, J D Douglas, et al.Digestion|July 11, 2003
GERD 2003 -- a consensus on the way aheadSteven F Moss, David Armstrong, Rudi Arnold, et al.Pageof 49